IBI302: Clinical Trials

1 trial of IBI302, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow IBI302: new trials by email Literature Review of IBI302 trials Research Report on IBI302

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD
Aflibercept Ophthalmic, IBI302 - Neovascular Age-related Macular Degeneration
Phase 3Active not recruitingInnovent Biologics (Suzhou) Co. Ltd.6002023-09-212025-03-13

Sponsors

Innovent Biologics (Suzhou) Co. Ltd. (1)

Countries

China (1)